What is Glutathione?

Glutathione is a powerful antioxidant peptide produced naturally in the body from three amino acids: cysteine, glycine, and glutamic acid (Wu et al., 2004). It plays crucial roles in reducing oxidative stress, detoxification, immune function, and overall health (Pizzorno, 2014). Glutathione is found in every cell of the human body and is essential for maintaining optimal health and longevity.

Low glutathione levels are associated with various chronic diseases and ageing (Ballatori et al., 2009). Factors contributing to glutathione deficiency include poor diet, environmental toxins, chronic stress, and certain medications. Maintaining adequate glutathione levels is crucial for preventing oxidative damage and supporting the body’s natural detoxification processes.

Glutathione Deficiency and Associated Health Risks

Glutathione deficiency has been linked to a wide range of health conditions, including cardiovascular disease, diabetes, neurodegenerative disorders, and cancer (Pizzorno, 2014). When glutathione levels are low, the body’s ability to neutralise harmful toxins and free radicals is compromised, leading to increased oxidative stress and cellular damage.

Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body’s ability to detoxify them (Biswas & Rahman, 2009). This imbalance can lead to damage to cellular components, including proteins, lipids, and DNA. Chronic oxidative stress has been implicated in the development and progression of numerous diseases, such as atherosclerosis, diabetes, and neurodegenerative disorders (Ballatori et al., 2009).

Glutathione plays a vital role in maintaining the balance between ROS production and antioxidant defence. It directly neutralises ROS and also serves as a cofactor for antioxidant enzymes, such as glutathione peroxidase (Pizzorno, 2014). When glutathione levels are depleted, the body’s ability to combat oxidative stress is significantly impaired, leading to an increased risk of cellular damage and disease.

Potential Health Benefits of Glutathione Supplementation

Reducing Oxidative Stress and Inflammation

As a potent antioxidant, glutathione neutralises harmful free radicals and oxidants, protecting cells from oxidative damage (Biswas & Rahman, 2009). By reducing oxidative stress, glutathione may help prevent the development and progression of chronic diseases associated with inflammation and cellular damage.

Numerous studies have demonstrated the beneficial effects of glutathione supplementation on oxidative stress markers. For example, a randomised, double-blind, placebo-controlled trial found that oral glutathione supplementation significantly reduced biomarkers of oxidative stress in healthy adults (Richie et al., 2015). Another study showed that intravenous glutathione administration reduced oxidative stress and improved insulin sensitivity in older adults with impaired glucose tolerance (Sekhar et al., 2011).

Glutathione’s antioxidant properties also contribute to its anti-inflammatory effects. Chronic inflammation is a hallmark of many diseases, including cardiovascular disease, diabetes, and autoimmune disorders. By reducing oxidative stress and regulating inflammatory pathways, glutathione may help attenuate the inflammatory response and protect against the development of these conditions (Biswas & Rahman, 2009).

Improving Skin Health and Psoriasis

Glutathione has been studied for its potential benefits in improving skin health and treating skin conditions like psoriasis. Psoriasis is a chronic inflammatory skin disorder characterised by red, scaly patches on the skin. Oxidative stress and inflammation are believed to play a role in the pathogenesis of psoriasis (Kadam et al., 2010).

Some studies suggest that increasing glutathione levels may improve psoriasis symptoms and overall skin health. A randomised, double-blind, placebo-controlled trial found that oral glutathione supplementation significantly improved psoriasis area and severity index (PASI) scores in patients with mild-to-moderate psoriasis (Weschawalit et al., 2017). The study also noted improvements in skin elasticity and hydration in the glutathione group compared to the placebo group.

The antioxidant and anti-inflammatory properties of glutathione may contribute to its beneficial effects on skin health. By reducing oxidative stress and inflammation in the skin, glutathione may help protect against cellular damage and promote a more youthful, healthy appearance (Weschawalit et al., 2017). However, more research is needed to fully understand the mechanisms behind glutathione’s effects on skin health and to establish optimal dosing and delivery methods for dermatological applications.

Supporting Liver Health and Detoxification

The liver is the primary site of detoxification in the body, and glutathione plays a crucial role in supporting liver health and function. Glutathione is involved in the liver’s phase II detoxification processes, which involve conjugating toxins and metabolites with glutathione to facilitate their elimination from the body (Loguercio & Di Pierro, 1999).

Glutathione has been studied for its potential benefits in various liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). NAFLD is characterised by the accumulation of fat in the liver, which can lead to inflammation, oxidative stress, and liver damage. A pilot study found that oral glutathione supplementation significantly reduced alanine aminotransferase (ALT) levels, a marker of liver damage, in patients with NAFLD (Honda et al., 2017).

Similarly, glutathione has been shown to have protective effects in ALD. Chronic alcohol consumption depletes glutathione levels in the liver, leading to increased oxidative stress and liver damage. A review of clinical trials found that glutathione supplementation significantly improved liver function and reduced oxidative stress markers in patients with ALD (Loguercio & Di Pierro, 1999).

Glutathione’s ability to support liver health and detoxification processes may have far-reaching implications for overall health and disease prevention. By enhancing the body’s ability to eliminate toxins and reduce oxidative stress in the liver, glutathione may help protect against the development of liver diseases and other chronic conditions associated with impaired detoxification (Pizzorno, 2014).

Enhancing Metabolic Health and Insulin Sensitivity

Glutathione has been studied for its potential benefits in improving metabolic health and insulin sensitivity. Insulin resistance, a hallmark of type 2 diabetes, is associated with increased oxidative stress and inflammation in the body (Lagman et al., 2015).

Higher glutathione levels have been associated with improved insulin sensitivity in older individuals. A study by Sekhar et al. (2011) found that glutathione supplementation improved insulin sensitivity and glucose tolerance in older adults with impaired glucose metabolism. The authors suggested that glutathione’s antioxidant properties may help reduce oxidative stress and inflammation, thereby improving insulin signalling and glucose uptake.

Another study investigated the relationship between glutathione levels and insulin resistance in individuals with type 2 diabetes. Lagman et al. (2015) found that patients with uncontrolled diabetes had significantly lower glutathione levels compared to healthy controls. The researchers also observed a significant inverse correlation between glutathione levels and insulin resistance, suggesting that lower glutathione levels may contribute to impaired insulin sensitivity in diabetes.

Glutathione supplementation has also been found to improve glucose control in people with uncontrolled diabetes. A randomised, double-blind, placebo-controlled trial by Lim et al. (2018) found that oral glutathione supplementation significantly reduced fasting blood glucose and HbA1c levels in patients with uncontrolled type 2 diabetes. The authors proposed that glutathione’s ability to reduce oxidative stress may be the primary mechanism behind its beneficial effects on glucose metabolism.

These findings suggest that glutathione may play an important role in regulating insulin sensitivity and glucose homeostasis. By reducing oxidative stress and inflammation, glutathione may help improve insulin signalling and glucose uptake, thereby enhancing metabolic health and reducing the risk of diabetes and its complications. However, more research is needed to fully elucidate the mechanisms behind glutathione’s effects on insulin sensitivity and to establish optimal dosing and delivery methods for metabolic health applications.

Improving Mobility in Peripheral Artery Disease (PAD)

Peripheral artery disease (PAD) is a condition characterised by reduced blood flow to the limbs due to narrowing of the arteries. PAD is associated with increased oxidative stress and inflammation in the blood vessels, which can lead to endothelial dysfunction and impaired circulation (Arosio et al., 2002).

Glutathione has been studied for its potential benefits in improving mobility and reducing symptoms in patients with PAD. A randomised, double-blind, placebo-controlled trial by Arosio et al. (2002) found that intravenous glutathione infusions significantly prolonged pain-free walking distance and improved blood circulation in patients with PAD. The authors suggested that glutathione’s antioxidant properties may help reduce oxidative stress and inflammation in the blood vessels, thereby improving endothelial function and circulation.

Another study by Sinha et al. (2009) investigated the effects of oral glutathione supplementation on walking ability in patients with PAD. The researchers found that glutathione supplementation significantly improved pain-free walking distance and quality of life scores compared to placebo. They proposed that glutathione’s ability to reduce oxidative stress and improve nitric oxide bioavailability may be the primary mechanisms behind its beneficial effects on PAD symptoms.

These findings suggest that glutathione may be a promising therapeutic option for improving mobility and reducing symptoms in patients with PAD. By reducing oxidative stress and inflammation in the blood vessels, glutathione may help improve endothelial function and circulation, thereby enhancing walking ability and quality of life. However, more research is needed to fully understand the optimal dosing and delivery methods for glutathione in the context of PAD treatment.

Potential Benefits for Neurological Conditions

Glutathione has been studied for its potential neuroprotective effects and benefits in various neurological conditions, such as Parkinson’s disease and Alzheimer’s disease. These neurodegenerative disorders are characterised by increased oxidative stress, inflammation, and mitochondrial dysfunction in the brain (Mischley et al., 2017; Saharan & Mandal, 2014).

Parkinson’s disease is a progressive neurological disorder that affects movement and is associated with the loss of dopaminergic neurons in the substantia nigra. Oxidative stress and mitochondrial dysfunction are believed to play a key role in the pathogenesis of Parkinson’s disease (Mischley et al., 2017). Some studies have found that glutathione supplementation can improve motor function and reduce symptoms in patients with Parkinson’s disease.

A randomised, double-blind, placebo-controlled trial by Mischley et al. (2017) found that intranasal glutathione supplementation significantly improved motor function and reduced disease severity in patients with Parkinson’s disease. The authors suggested that glutathione’s ability to reduce oxidative stress and support mitochondrial function may be the primary mechanisms behind its neuroprotective effects.

Similarly, a pilot study by Sechi et al. (1996) found that intravenous glutathione supplementation improved motor function and reduced disability in patients with early Parkinson’s disease. The researchers proposed that glutathione’s antioxidant properties may help protect dopaminergic neurons from oxidative damage and slow the progression of the disease.

Glutathione has also been studied for its potential benefits in Alzheimer’s disease, a neurodegenerative disorder characterised by progressive cognitive decline and memory loss. Oxidative stress and inflammation are believed to contribute to the pathogenesis of Alzheimer’s disease (Saharan & Mandal, 2014). Some studies have suggested that glutathione supplementation may help reduce oxidative stress and improve cognitive function in patients with Alzheimer’s disease.

A review by Saharan and Mandal (2014) highlighted the potential neuroprotective effects of glutathione in Alzheimer’s disease. The authors discussed evidence suggesting that glutathione depletion may contribute to the oxidative stress and neuronal damage observed in Alzheimer’s disease. They proposed that glutathione supplementation may help reduce oxidative stress, protect neurons from damage, and slow the progression of cognitive decline.

While these findings are promising, more research is needed to fully understand the potential benefits of glutathione supplementation in neurological conditions. Large-scale, well-designed clinical trials are necessary to establish the efficacy, optimal dosing, and long-term safety of glutathione supplementation in the context of neurodegenerative disorders. Additionally, further research is needed to elucidate the specific mechanisms behind glutathione’s neuroprotective effects and to identify the most effective delivery methods for targeting the brain.

Supporting Immune Function and Autoimmune Diseases

Glutathione plays a crucial role in regulating immune function and has been studied for its potential benefits in various autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis. Autoimmune diseases are characterised by an overactive immune response, leading to chronic inflammation and tissue damage (Perricone et al., 2009).

Glutathione helps regulate immune response by modulating the activity of immune cells, such as T lymphocytes and natural killer cells (Perricone et al., 2009). It also plays a role in the production of cytokines, which are signalling molecules that regulate inflammation and immune function. Glutathione deficiency has been associated with impaired immune function and increased susceptibility to infections and autoimmune diseases (Ballatori et al., 2009).

Some studies have suggested that glutathione supplementation may help reduce inflammation and improve symptoms in patients with autoimmune diseases. A review by Perricone et al. (2009) discussed the potential benefits of glutathione in rheumatoid arthritis, an autoimmune disease characterised by chronic inflammation and joint damage. The authors highlighted evidence suggesting that glutathione deficiency may contribute to the oxidative stress and inflammation observed in rheumatoid arthritis. They proposed that glutathione supplementation may help reduce inflammation, protect joints from damage, and improve disease outcomes.

Similarly, a review by Saharan and Mandal (2014) discussed the potential benefits of glutathione in multiple sclerosis, an autoimmune disease that affects the central nervous system. The authors presented evidence suggesting that glutathione depletion may contribute to the oxidative stress and neuronal damage observed in multiple sclerosis. They proposed that glutathione supplementation may help reduce inflammation, protect neurons from damage, and slow the progression of the disease.

While these findings are promising, more research is needed to fully understand the potential benefits of glutathione supplementation in autoimmune diseases. Large-scale, well-designed clinical trials are necessary to establish the efficacy, optimal dosing, and long-term safety of glutathione supplementation in the context of autoimmune disorders. Additionally, further research is needed to elucidate the specific mechanisms behind glutathione’s immunomodulatory effects and to identify the most effective delivery methods for targeting the immune system.

Potential Benefits for Autism Spectrum Disorders

Autism spectrum disorders (ASD) are neurodevelopmental conditions characterised by impairments in social interaction, communication, and behaviour. Oxidative stress and inflammation have been implicated in the pathogenesis of ASD, and some studies have suggested that children with ASD may have lower glutathione levels compared to typically developing children (Kern et al., 2011; Frustaci et al., 2012).

A clinical trial by Kern et al. (2011) investigated the effects of oral glutathione supplementation on oxidative stress markers and behaviour in children with ASD. The researchers found that glutathione supplementation significantly increased plasma glutathione levels and reduced oxidative stress markers in the treatment group compared to placebo. They also observed improvements in social interaction and communication skills in the glutathione group, although these changes were not statistically significant.

Another study by Frustaci et al. (2012) conducted a systematic review and meta-analysis of oxidative stress markers in ASD. The authors found that children with ASD had significantly lower glutathione levels and higher markers of oxidative damage compared to typically developing children. They suggested that glutathione deficiency may contribute to the oxidative stress and neurological impairments observed in ASD.

These findings suggest that glutathione supplementation may be a promising therapeutic approach for reducing oxidative stress and improving symptoms in children with ASD. By increasing glutathione levels and reducing oxidative damage, glutathione supplementation may help support brain function and development in children with ASD. However, more research is needed to fully understand the potential benefits and limitations of glutathione supplementation in ASD.

Large-scale, well-designed clinical trials are necessary to establish the efficacy, optimal dosing, and long-term safety of glutathione supplementation in children with ASD. Additionally, further research is needed to elucidate the specific mechanisms behind glutathione’s effects on brain function and behaviour in ASD and to identify the most effective delivery methods for targeting the brain.

It is important to note that while glutathione supplementation may be a promising adjunctive therapy for ASD, it should not be considered a standalone treatment. A comprehensive approach to ASD management should include behavioural interventions, educational support, and other evidence-based therapies as appropriate. Parents and

Key Highlights and Actionable Tips

• Glutathione is a powerful antioxidant produced naturally in the body from three amino acids: cysteine, glycine, and glutamic acid
• Low glutathione levels are associated with various chronic diseases and ageing
• Maintaining adequate glutathione levels is crucial for preventing oxidative damage and supporting the body’s natural detoxification processes
• Glutathione supplementation may help reduce oxidative stress, inflammation, and improve overall health
• Consuming a diet rich in glutathione-boosting foods, such as cruciferous vegetables, whey protein, and sulfur-rich foods, can help support glutathione production

What are some factors that can contribute to glutathione deficiency?

Several factors can contribute to glutathione deficiency, including:

1. Poor diet: A diet lacking in essential nutrients, such as amino acids (cysteine, glycine, and glutamic acid), vitamins (C and E), and minerals (selenium), can hinder the body’s ability to produce glutathione.

2. Chronic stress: Prolonged exposure to stress can deplete glutathione levels by increasing the production of free radicals and oxidative stress.

3. Environmental toxins: Exposure to pollutants, heavy metals, and other environmental toxins can increase the body’s demand for glutathione to neutralise these harmful substances.

4. Certain medications: Some medications, such as acetaminophen and chemotherapy drugs, can deplete glutathione levels by increasing oxidative stress or interfering with glutathione synthesis.

5. Ageing: As we age, our body’s ability to produce glutathione naturally declines, making it more challenging to maintain optimal levels.

How can I naturally boost my glutathione levels through diet?

You can naturally boost your glutathione levels through diet by consuming foods rich in the amino acids and nutrients needed for glutathione synthesis. Some glutathione-boosting foods include:

1. Cruciferous vegetables: Broccoli, cauliflower, kale, and Brussels sprouts contain sulforaphane, which helps stimulate glutathione production.

2. Whey protein: Whey protein is rich in cysteine, one of the amino acids required for glutathione synthesis.

3. Sulfur-rich foods: Garlic, onions, and leeks contain sulfur compounds that help support glutathione production.

4. Vitamin C-rich foods: Citrus fruits, berries, and leafy greens are high in vitamin C, which helps recycle glutathione and maintain its antioxidant function.

5. Selenium-rich foods: Brazil nuts, sardines, and grass-fed beef are good sources of selenium, a mineral that plays a crucial role in glutathione peroxidase, an antioxidant enzyme.

Are there any potential side effects or precautions to consider when taking glutathione supplements?

While glutathione supplements are generally considered safe, there are some potential side effects and precautions to consider:

1. Digestive issues: Oral glutathione supplements may cause mild digestive discomfort, such as bloating or diarrhoea, in some individuals.

2. Allergic reactions: Some people may experience allergic reactions to glutathione supplements, particularly if they are sensitive to the ingredients used in the formulation.

3. Drug interactions: Glutathione supplements may interact with certain medications, such as chemotherapy drugs, by altering their effectiveness or increasing the risk of side effects.

4. Lack of regulation: Dietary supplements are not strictly regulated by the Therapeutic Goods Administration (TGA), so the quality and purity of glutathione supplements may vary between brands.

5. Limited long-term safety data: While short-term use of glutathione supplements appears to be safe, there is limited data on the long-term safety of these supplements.

It is always advisable to consult with a healthcare professional before starting any new supplement regimen, especially if you have pre-existing health conditions or are taking medications.

Can glutathione supplementation improve skin health and appearance?

Yes, glutathione supplementation may improve skin health and appearance by:

1. Reducing oxidative stress: As a potent antioxidant, glutathione helps neutralise harmful free radicals that can damage skin cells and accelerate the ageing process.

2. Promoting collagen production: Glutathione plays a role in the synthesis of collagen, a protein that helps maintain skin elasticity and firmness.

3. Improving skin hydration: Some studies suggest that glutathione supplementation can improve skin hydration and moisture retention, leading to a more youthful and supple appearance.

4. Reducing hyperpigmentation: Glutathione has been shown to inhibit the production of melanin, the pigment responsible for skin discolouration and dark spots.

5. Supporting skin repair: By reducing inflammation and supporting the body’s natural healing processes, glutathione may help improve the appearance of scars, blemishes, and other skin imperfections.

While glutathione supplementation shows promise for improving skin health and appearance, more research is needed to fully understand its effects and determine the optimal dosing and delivery methods for dermatological applications.

How does glutathione support the body’s natural detoxification processes?

Glutathione supports the body’s natural detoxification processes in several ways:

1. Conjugation: Glutathione binds to toxins, such as heavy metals and environmental pollutants, forming a water-soluble compound that can be more easily excreted from the body through urine or bile.

2. Antioxidant defence: As a powerful antioxidant, glutathione neutralises harmful free radicals and reactive oxygen species that can damage cells and contribute to oxidative stress.

3. Supporting phase II detoxification: Glutathione is involved in the liver’s phase II detoxification processes, which involve conjugating toxins and metabolites to facilitate their elimination from the body.

4. Regenerating other antioxidants: Glutathione helps recycle other important antioxidants, such as vitamin C and vitamin E, maintaining their effectiveness in combating oxidative stress.

5. Protecting cellular components: By reducing oxidative stress and inflammation, glutathione helps protect cellular components, such as proteins, lipids, and DNA, from damage caused by toxins and free radicals.

Maintaining adequate glutathione levels is crucial for supporting the body’s natural detoxification processes and promoting overall health. A diet rich in glutathione-boosting nutrients, along with lifestyle factors that reduce oxidative stress, can help optimise the body’s detoxification pathways.

References

Arosio, E., De Marchi, S., Zannoni, M., Prior, M., & Lechi, A. (2002). Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial. Mayo Clinic Proceedings, 77(8), 754-759. https://doi.org/10.4065/77.8.754

Ballatori, N., Krance, S. M., Notenboom, S., Shi, S., Tieu, K., & Hammond, C. L. (2009). Glutathione dysregulation and the etiology and progression of human diseases. Biological Chemistry, 390(3), 191-214. https://doi.org/10.1515/BC.2009.033

Biswas, S. K., & Rahman, I. (2009). Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Molecular Aspects of Medicine, 30(1-2), 60-76. https://doi.org/10.1016/j.mam.2008.07.001

Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Dalla Bernardina, B., & Bonassi, S. (2012). Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radical Biology & Medicine, 52(10), 2128-2141. https://doi.org/10.1016/j.freeradbiomed.2012.03.011

Honda, Y., Kessoku, T., Sumida, Y., Kobayashi, T., Kato, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Kataoka, K., Taguri, M., Yamanaka, T., Seko, Y., Tanaka, S., Saito, S., Ono, M., Oeda, S., Eguchi, Y., Aoi, W., … Nakajima, A. (2017). Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterology, 17(1), 96. https://doi.org/10.1186/s12876-017-0652-3

Kern, J. K., Geier, D. A., Adams, J. B., Garver, C. R., Audhya, T., & Geier, M. R. (2011). A clinical trial of glutathione supplementation in autism spectrum disorders. Medical Science Monitor, 17(12), CR677-CR682. https://doi.org/10.12659/msm.882125

Lagman, M., Ly, J., Saing, T., Kaur Singh, M., Vera Tudela, E., Morris, D., Chi, P. T., Ochoa, C., Sathananthan, A., & Venketaraman, V. (2015). Investigating the causes for decreased levels of glutathione in individuals with type II diabetes. PloS One, 10(3), e0118436. https://doi.org/10.1371/journal.pone.0118436

Loguercio, C., & Di Pierro, M. (1999). The role of glutathione in the gastrointestinal tract: a review. Italian Journal of Gastroenterology and Hepatology, 31(5), 401-407.

Mischley, L. K., Lau, R. C., Shankland, E. G., Wilbur, T. K., & Padowski, J. M. (2017). Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease. Journal of Parkinson’s Disease, 7(2), 289-299. https://doi.org/10.3233/JPD-161040

Perricone, C., De Carolis, C., & Perricone, R. (2009). Glutathione: a key player in autoimmunity. Autoimmunity Reviews, 8(8), 697-701. https://doi.org/10.1016/j.autrev.2009.02.020

Pizzorno J. (2014). Glutathione!. Integrative Medicine (Encinitas, Calif.), 13(1), 8-12.

Prousky J. E. (2008). The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione. Evidence-Based Complementary and Alternative Medicine, 5(1), 27-35. https://doi.org/10.1093/ecam/nem040

Saharan, S., & Mandal, P. K. (2014). The emerging role of glutathione in Alzheimer’s disease. Journal of Alzheimer’s Disease, 40(3), 519-529. https://doi.org/10.3233/JAD-132483

Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996). Reduced intravenous glutathione in the treatment of early Parkinson’s disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 20(7), 1159-1170. https://doi.org/10.1016/s0278-5846(96)00103-0

Sekhar, R. V., McKay, S. V., Patel, S. G., Guthikonda, A. P., Reddy, V. T., Balasubramanyam, A., & Jahoor, F. (2011). Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care, 34(1), 162-167. https://doi.org/10.2337/dc10-1006

Testa, B., Testa, D., Mesolella, M., D’Errico, G., Tricarico, D., & Motta, G. (2001). Management of chronic otitis media with effusion: the role of glutathione. The Laryngoscope, 111(8), 1486-1489. https://doi.org/10.1097/00005537-200108000-00030

Weschawalit, S., Thongthip, S., Phutrakool, P., & Asawanonda, P. (2017). Glutathione and its antiaging and antimelanogenic effects. Clinical, Cosmetic and Investigational Dermatology, 10, 147-153. https://doi.org/10.2147/CCID.S128339

Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R., & Turner, N. D. (2004). Glutathione metabolism and its implications for health. The Journal of Nutrition, 134(3), 489-492. https://doi.org/10.1093/jn/134.3.489